Related Experiment Video

Updated: Aug 13, 2026

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

Emerging concepts in GPCR function--the influence of cell phenotype on GPCR pharmacology

Richard M Eglen1

  • 1DiscoveRx Corp, 42501 Albrae St., Fremont, CA 94538, USA. reglen@discoverx.com

Proceedings of the Western Pharmacology Society
|January 19, 2006
PubMed

Insights

Cellular environment significantly impacts G protein-coupled receptor (GPCR) function and ligand interactions. Understanding these phenotypic influences is crucial for accurate GPCR drug discovery and development.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Pharmacology

Background:

  • G protein-coupled receptors (GPCRs) are critical regulators of cellular metabolism.
  • GPCR function is increasingly recognized as dependent on the cellular environment.
  • Cell phenotype influences GPCR activation, signaling, and ligand binding.

Purpose of the Study:

  • To review the phenotypic influences on GPCR function.
  • To discuss the implications for cell-based assays in GPCR ligand discovery.
  • To highlight tissue-specific responses mediated by GPCR signaling.

Main Methods:

  • Literature review of studies investigating GPCR function in different cellular contexts.
  • Analysis of how cell phenotype affects GPCR oligomerization, G protein coupling, and downstream signaling.
  • Evaluation of the impact of cellular environment on agonist affinity and efficacy.

Main Results:

  • Cell phenotype modulates GPCR activation pathways, including protein interactions and localization.
  • Cellular environment significantly alters the affinity and efficacy of both endogenous agonists and synthetic ligands.
  • GPCR signaling exhibits complex, tissue-specific responses even for the same receptor subtype.

Conclusions:

  • The cellular environment is a critical determinant of GPCR function and signaling outcomes.
  • Phenotypic influences must be considered when interpreting data from cell-based GPCR assays.
  • Understanding cell-specific GPCR behavior is essential for developing targeted therapeutics.

More Related Videos

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Characterization of G Protein-coupled Receptors by a Fluorescence-based Calcium Mobilization Assay11:49

Characterization of G Protein-coupled Receptors by a Fluorescence-based Calcium Mobilization Assay

Published on: July 28, 2014

Related Concept Videos

Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...